BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6585681)

  • 21. [Possibility of overcoming of ACNU resistance in an ACNU-resistant subline of C6 rat glioma].
    Yoshida T; Shimizu K; Ushio Y; Mogami H; Sakamoto Y
    No To Shinkei; 1986 Nov; 38(11):1065-70. PubMed ID: 3468959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Synchronization chemoradiotherapy for malignant gliomas].
    Yamamoto H; Sato F; Nakamura O; Kohno T; Shitara N; Takakura K; Sano K; Maehara T; Akanuma A
    No Shinkei Geka; 1984 Jun; 12(7):795-805. PubMed ID: 6592471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma.
    Weller M; Müller B; Koch R; Bamberg M; Krauseneck P;
    J Clin Oncol; 2003 Sep; 21(17):3276-84. PubMed ID: 12947063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrathecal chemotherapy with ACNU in a meningeal gliomatosis rat model.
    Yoshida TK; Shimizu K; Koulousakis A; Sturm V
    J Neurosurg; 1992 Nov; 77(5):778-82. PubMed ID: 1403122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of perfluorochemicals on BCNU chemotherapy in a rat brain-tumor model].
    Kokunai T; Kuwamura K
    No To Shinkei; 1982 Jun; 34(6):609-15. PubMed ID: 7115598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue distribution and antitumor activity of topotecan delivered by intracerebral clysis in a rat glioma model.
    Kaiser MG; Parsa AT; Fine RL; Hall JS; Chakrabarti I; Bruce JN
    Neurosurgery; 2000 Dec; 47(6):1391-8; discussion 1398-9. PubMed ID: 11126910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of X-rays combined with ACNU and O6-ethylguanine on rat subcutaneous gliomas].
    Takahashi K; Katakura R; Mashiyama S; Yoshimoto T; Suzuki J; Sasaki T
    No Shinkei Geka; 1991 Jun; 19(6):531-8. PubMed ID: 1881522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood-brain barrier disruption and methotrexate in the treatment of a readily transplantable intracerebral osteogenic sarcoma of rats.
    Cosolo W; Christophidis N
    Cancer Res; 1987 Dec; 47(23):6225-8. PubMed ID: 3119195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of experimental models for meningeal neoplasia using intrathecal injection of 9L gliosarcoma and Walker 256 carcinosarcoma in the rat.
    Kooistra KL; Rodriguez M; Powis G; Yaksh TL; Harty GJ; Hilton JF; Laws ER
    Cancer Res; 1986 Jan; 46(1):317-23. PubMed ID: 3753551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alteration of blood-CSF barrier by tumor invasion into the meninges.
    Ushio Y; Shimizu K; Aragaki Y; Arita N; Hayakawa T; Mogami H
    J Neurosurg; 1981 Sep; 55(3):445-9. PubMed ID: 6943305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Multidisciplinary treatment of metastatic brain tumor and its fundamental studies for chemo-immunotherapy].
    Kobayashi T
    Gan No Rinsho; 1984 Jul; 30(9 Suppl):1022-9. PubMed ID: 6332206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrathecal chemotherapy with ACNU for meningeal gliomatosis.
    Yoshida TK; Beuls E; Shimizu K; Koulousakis A; Sturm V
    Br J Cancer; 1992 Dec; 66(6):999-1004. PubMed ID: 1457369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Development of ACNU-resistant meningeal gliomatosis models: establishment of resistant rat glioma subline against ACNU].
    Yoshida T; Ushio Y; Hayakawa T; Yamada K; Kato A; Mogami H; Nakata Y
    No Shinkei Geka; 1984 Aug; 12(9):1029-36. PubMed ID: 6594599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of ACNU against experimental brain tumor--immunohistochemical study using anti-BrdU monoclonal antibody].
    Izumoto S; Arita N; Ushio Y; Hayakawa T; Yoshimine T; Tzuu-Yuan H; Nagatani M; Oku Y; Mogami H
    No To Shinkei; 1988 Nov; 40(11):1095-9. PubMed ID: 3219244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemotherapy of an experimental glioma with nitrosoureas.
    Tator CH; Day A; Ng R; Liberman L
    Cancer Res; 1977 Feb; 37(2):476-81. PubMed ID: 832271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Subarachnoid dissemination of the brain tumor cells (author's transl)].
    Matsukado Y; Uemura S; Kuratsu J
    No Shinkei Geka; 1980 Dec; 8(12):1113-23. PubMed ID: 6454080
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical efficacy of a quadruple combination chemotherapy with ACNU, adriamycin, methotrexate, and prednisolone for patients with non-Hodgkin's lymphoma, who were refractory to VEPA (P) treatment].
    Niitsu H; Fukuda M; Fukuda S; Takatsu H; Nakayama Y; Hirokawa M; Mamiya S; Miura I; Takahashi F; Yoshida K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2585-9. PubMed ID: 6594975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implantable polymers for tirapazamine treatments of experimental intracranial malignant glioma.
    Yuan X; Tabassi K; Williams JA
    Radiat Oncol Investig; 1999; 7(4):218-30. PubMed ID: 10492162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of MX-2, a morpholino anthracycline derivative, against human and rat glioma cells and experimental leptomeningeal tumors in rats].
    Izumoto S; Arita N; Ushio Y; Hayakawa T; Ohnishi T; Taki T; Yamamoto H; Oku Y; Mogami H; Komeshima N
    Gan To Kagaku Ryoho; 1988 May; 15(5):1765-9. PubMed ID: 3369870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [MCNU effectiveness on brain tumor. Part I: Antitumor activity in vitro on human glioma and neuroblastoma cell lines].
    Wakabayashi T; Yoshida J; Inoue I; Kageyama N; Nagata M; Kanzaki M
    Gan To Kagaku Ryoho; 1984 May; 11(5):1098-106. PubMed ID: 6586113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.